Vanguard Group Inc made a significant addition to its portfolio by acquiring 9,018,094 shares of Edwards Lifesciences Corp ...

Shares of Edwards Lifesciences Corp. EW inched 0.18% higher to $65.49 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.90% ...

Edwards Lifesciences Corp (EW) stock saw a modest uptick, ending the day at $65.37 which represents a slight increase of $0.22 or 0.34% from the prior close of $65.15. The stock opened at $64.86 and ...

Background Significant secondary mitral regurgitation (SMR) is known to be associated with worse prognosis. However, data ...

It has been a blockbuster year for women's health as the federal government and medtech place special focus on the wellbeing ...

Edwards Lifesciences Corporation (EW), headquartered in Irvine, California, provides products and technologies for structural ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on TransMedics Group (TMDX – Research Report), Vertex ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Edwards Lifesciences (EW – Research Report), ...

Edward Lifesciences' Critical Care divestiture bodes well for its Structural Heart portfolio. Yet, macroeconomic issues raise worry for its operations.

Report Ocean, a leading strategic consulting and market research firm, in its recent study, estimated the Global Neurovascular Thrombectomy Devices Market size at USD 2.17 billion in 2023. During the ...

The Galien Foundation recently announced the nominees for its "Best Medical Technology" Pix Galien USA awards.

Citi upgrades Becton Dickinson (BDX) to buy, puts Tandem (TNDM) on a Negative Catalyst Watch and maintains a Positive ...